that article is garbage and is merely an opinion piece. Got to understand how far the evaluation dropped based on the fact FDA had denied their application twice and things were looking grim. The IPO evaluation was significantly more and was floated at an issue price of $1.25 in July of 2021. Fast forward two years, and we now have FDA approval and a significant discount to our market cap, even accounting for cap raise dilution.
LDX Price at posting:
15.5¢ Sentiment: None Disclosure: Held
